JPRN-UMIN000035292Recruiting未知
A Multicenter study on the proper use and safety of ponatinib based on PK/PD/PGx - A Multicenter study on the proper use and safety based on PK/PD/PGx
ational Cancer Center Hospital East0 sites70 target enrollmentStarted: December 17, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
A Multicenter study of the safety and efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in patients with hypophosphatasia (HPP)hypophosphatasiaJPRN-UMIN000014816HPP study group20
Active, not recruiting
Not Applicable
A Multicenter study on the efficacy and safety of Vivaglobin in Previously Untreated Patients (PUPs) with Primary Immunodeficiency (PID) - NDPatients with PID diseases as Common Variable Immunodeficiency (CVID) or X-linked agammaglobulinemia ( XLA), age 1 to 70 years.MedDRA version: 6.1Level: PTClassification code 10057863EUCTR2006-006522-25-ITCSL Behring AG28
Completed
Not Applicable
A multicentre study of the safety and efficacy of N-acetylcysteine in the treatment of acute liver failure in paediatric patients not caused by acetaminopheAcute liver failureTopic: Medicines for Children Research NetworkSubtopic: All DiagnosesDisease: All DiseasesDigestive SystemISRCTN36658311King's College Hospital NHS Foundation Trust (UK)28
Completed
Not Applicable
A multi-center study of the safety and efficacy of the percutaneous transvenous mitral annuloplasty system to reduce mitral valve regurgitation in patients with heart failure.mitral regurgitationmitral valve leakage10046973NL-OMON33252Viacor Inc.14
Active, not recruiting
Not Applicable
A multicenter study on the efficacy and safety of Vivaglobin® in Previously Untreated Patients (PUPs) with Primary Immunodeficiency (PID)EUCTR2006-006522-25-BECSL Behring AG28